Diabetes-Associated Biobanking: More Topical Than Ever?

Abstract

The increasing prevalence of diabetes and its accompanying long-term complications, as well as the associated economic burden, calls for a rapid clinical translation of biomedical research to better valid the physiological relevance of the findings from basic research. To meet this condition, the Collaborative Research Center (CRC) 1118 has established the first nationwide diabetes-specific Biomaterialbank (BMB) that permanently preserves solid and liquid specimen retro- and prospectively at the Institute of Pathology and Department of Endocrinology of the University Hospital Heidelberg. The main purpose of this BMB is to collect, preserve, characterize and provide human diabetic specimen to researchers investigating the role of reactive metabolites (RM) as cause of diabetic late complications. In this review we discuss the urgent need to support translational and clinical research projects by making use of diabetic solid and liquid specimen and provide an insight into the organization and general conditions of biobanking procedures which are pivotal to guaranteeing high-quality human biomaterial. In light of diabetes-tailored biobanking, we describe our newly initiated activities and introduce the diverse technology platforms that can be used for the investigation of promising molecular targets pertinent for diabetes. With this article we demonstrate that the preservation of rare specimen is also particularly relevant in the non-neoplastic field and contributes to basic investigation, promotes comprehensive scientific data and fortifies the sustainability for diabetes research. In addition, the increased understanding of how metabolic imbalance triggers diabetes onset and progression and favors diabetic late symptoms might hold some promise for future innovative diagnostic and/ or therapeutic applications, eventually adding to the improvement of patient care.

Key words

diabetes - long-term complications - basic research - biobanking - immunohistochemistry

• References

• 1 International Diabetes Federation. IDF Diabetes Atlas. 7 ed. Brussels, Belgium: International Diabetes Federation; 2015. http://www.diabetesatlas.org
• 2 van’t Riet E, Alssema M, Rijkelijkhuizen JM. et al. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 2010; 33: 61-66
• 3 Selvin E, Wattanakit K, Steffes MW. et al. HbA1c and peripheral arterial disease in diabetes: the atherosclerosis risk in communities study. Diabetes Care 2006; 29: 877-882
• 4 Skriver MV, Borch-Johnsen K, Lauritzen T. et al. HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION), Denmark. Diabetologia 2010; 53: 2328-2333
• 5 Jager A, Kostense PJ, Nijpels G. et al. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 1998; 41: 694-700
• 6 Fleming T, Cuny J, Nawroth G. et al. Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?. Diabetologia 2012; 55: 1151-1155
• 7 Nagai R, Murray DB, Metz TO. et al. Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes 2012; 61: 549-559
• 8 Schmitt S, Kynast K, Schirmacher P. et al. Maintainance of a research tissue bank. (Infra)structural and quality aspects. Pathologe 2015; 36 (Suppl. 02) 205-209
• 9 Herpel E, Hummel M. Research biobanks–development and structure. Dtsch Med Wochenschr 2012; 138: 1069-1072
• 10 Simeon-Dubach D, Perren A. Better provenance for biobank samples. Nature 2011; 27 475: 454-455
• 11 Herpel E, Koleganova N, Schirmacher P. Tissue bank of the National centre for tumour disease. An innovative platform for translational tumour. Pathologe 2008; 29 (Suppl. 02) 204-209
• 12 Schmitt S, Kynast K, Schirmacher P. et al. Challenges for quality management in implementation, maintenance, and sustainability of research tissue biobanks. Virchows Arch 2016; 468: 93-99
• 13 Herpel E, Koleganova N, Schreiber B. et al. Structural requirements of research tissue banks derived from standardized project surveillance. Virchows Arch 2012; 461: 79-86
• 14 Kender Z, Fleming T, Kopf S. et al. Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 2014; 122: 316-319
• 15 Kopf S, Oikonomou D, Hartmann M. et al. Effects of stress reduction on cardiovascular risk factors in type 2 diabetes patients with early kidney disease – results of a randomized controlled trial (HEIDIS). Exp Clin Endocrinol Diabetes 2014; 122: 341-349
• 16 Hidmark A, Fleming T, Vittas S. et al. A new paradigm to understand and treat diabetic neuropathy. Exp Clin Endocrinol Diabetes 2014; 122: 201-207
• 17 Mendler M, Schlotterer A, Morcos M. et al. Understanding diabetic polyneuropathy and longevity: what can we learn from the nematode Caenorhabditis elegans?. Exp Clin Endocrinol Diabetes 2012; 120: 182-183
• 18 Tyedmers J. Yeast as a model to understand mechanisms and consequences of protein modifications by metabolism derived toxic products. Exp Clin Endocrinol Diabetes 2012; 120: 179-181
• 19 ISO 2015; http://www.iso.org/iso/home/standards_development/list_of_iso_technical_committees/iso_technical_committee.htm?commid = 4514241